Virios Therapeutics (VIRI) Reports Q4 Loss of $1.25/sh
Tweet
Share
E-mailGet Alerts VIRI Hot Sheet
Join SI Premium – FREE
Virios Therapeutics (NASDAQ: VIRI) reported Q4 EPS of ($1.25), versus ($0.13) reported last year.
For earnings history and earnings-related data on Virios Therapeutics (VIRI) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Barrick Mining said to delay IPO of American gold business to 2027
- Tilly's, Inc. (TLYS) Tops Q2 EPS by 10c, Beats on Revenue
- Sprinklr (CXM) Tops Q2 EPS by 1c, Offers Guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
